<DOC>
	<DOCNO>NCT02404415</DOCNO>
	<brief_summary>The Vanderbilt Atrial Fibrillation Ablation registry ( VAFAR ) prospective clinical genetic biorepository systematically enroll patient undergo atrial fibrillation ( AF ) ablation . The registry start 2011 great 1000 AF ablation record store blood DNA sample . The goal VAFAR : 1 ) identify clinical , genetic , serological predictor response AF ablation order improve patient selection , 2 ) provide resource translational research investigate electrophysiologic mechanism AF pathogenesis .</brief_summary>
	<brief_title>The Vanderbilt Atrial Fibrillation Ablation Registry</brief_title>
	<detailed_description>The study population consist patient least 18 year age schedule AF ablation Vanderbilt University . Data record enrollment include detailed past medical history measurement pre-ablation imaging ( cardiac MRI CT ) . At time ablation , blood sample collect storage plasma/serum extraction DNA , detail ablation procedure record . Post-ablation monitoring arrhythmia recurrence perform accord standard clinical follow-up schedule 3 , 6 , 12-months . ECG 's perform follow-up visit along placement ambulatory ECG-monitor . At 6-months post-ablation , cardiac imaging repeat cardiac MRI CT perform .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Inclusion criterion : 1 . Age &gt; 18 year 2 . Able give write , inform consent 3 . Scheduled ablation procedure treat atrial fibrillation Exclusion criterion : 1 . None</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>catheter ablation</keyword>
	<keyword>genomics</keyword>
</DOC>